AstraZeneca
Job cuts at AstraZeneca’s US manufacturing plant
May 24, 2011Manufacturing and Production AstraZeneca, job cuts
AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …
GSK takes lead role in UK personalised medicine programme
May 20, 2011Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine
The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
GSK and AZ collaborate on translational research centre
May 12, 2011Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research
The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
AZ signs targeted colon cancer drug collaboration
May 11, 2011Research and Development AstraZeneca, colorectal cancer, personalised medicine
AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …
AZ gets green light for thyroid cancer drug
April 7, 2011Sales and Marketing AstraZeneca, zactima
AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …
AstraZeneca pays $1.1bn to resolve tax affairs
March 31, 2011Sales and Marketing AstraZeneca, tax
AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …
Bayer-helmed oncology biomarker project launched
March 14, 2011Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology
A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …
AZ partners with Galderma on psoriasis research
March 9, 2011Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis
AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …
AZ stops making Pulmicort pMDI inhaler
March 8, 2011Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide
AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …
Onglyza expands European licence
March 4, 2011Sales and Marketing AZ, AstraZeneca, BMS, Bristol-Myers Squibb, Onglyza, diabetes, renal impairment, saxagliptin, type II diabetes
European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …
AZ opens new global HQ in London
February 28, 2011Medical Communications, Sales and Marketing AZ, AstraZeneca, London
AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …
AstraZeneca plans $150m plant in Russia
February 22, 2011Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing
AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …
AZ accepts $92.5m to settle respiratory dispute
February 18, 2011Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory
AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …
Digital Pharma: AZ presses the case for social media in pharma
February 11, 2011Medical Communications AZ, AstraZeneca, Digital Pharma blog, FDA, social media
Seemingly fed up with waiting for the FDA’s delayed social media guidance, AstraZeneca has published details of its own feedback …
Pharma-NHS diabetes project begins
February 9, 2011Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working
A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
